The kidney in heart failure

著者

• Bakris, George L.

書誌事項

The kidney in heart failure

George L. Bakris, editor

Springer, c2012

注記

Includes bibliographical references and index

内容説明・目次

内容説明

Chronic Kidney Disease (CKD) is a recognized risk factor for cardiovascular events and death. The coexistence of CKD and heart failure is increasing in prevalence worldwide and requires a unique and subtle approach to patient management. The Kidney in Heart Failure focuses on the changes that occur in kidney physiology as a function of a failing heart. This comprehensive resource covers epidemiology, pathophysiology, management of kidney disorders and advances in nephropathy management. In addition, the latest therapies, common heart failure dilemmas and kidney disease markers are included. Each chapter is co-authored by a Nephrologist and Cardiologist, offering a unified perspective to these chronic conditions. This indispensible volume provides the reader with the depth-of-knowledge needed for assessing and treating the cardio renal patient.

目次

Foreword Peter A. McCulloughPrefacePart One EpidemiologyChapter 1 Epidemiology of Chronic Kidney Disease in Heart Failure Ruth C. Campbell and Ali Ahmed Chapter 2 Anemia and Cardiovascular Risk in the Kidney Disease Patients: What is the best way to achieve and what is the desired hemoglobin? Tejas V. Patel and Ajay K. Singh Part Two PathophysiologyChapter 3 Renal Hemodynamic Changes in Heart Failure Ivana Lazich and George L. Bakris Chapter 4 Changes in Kidney Function Following Heart Failure Treatment: Focus on RAS Blockade Mohammed Shakaib and George L. Bakris Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient Biff F. Palmer Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications Ivan D. Hanson and Peter A. McCullough Part Three Management of Kidney Associated Clinical ProblemsChapter 7 Hyperkalemia Risk and Treatment of Heart Failure Julian Segura and Luis M. Ruilope Chapter 8 Management of Heart Failure with Renal Artery Ischaemia Andrew K. Roy and Patrick Murray Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options Domenic A. Sica Chapter 11 Ultrafiltration and Heart Failure Paul Chacko, Donald Kikta Jr., William T. Abraham Part Four Advances in Nephropathy Management: Influences on CVD RiskChapter 12 Combination Therapy in Hypertension Treatment Raymond V. Oliva and George L. Bakris Chapter 13 Medication Adherence in Heart Failure Daniel E. Hilleman and Jennifer A. Campbell Chapter 14 New Markers of Vascular Risk David Davidson and Michael H. Davidson Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD Raghu V. Durvasula and Katherine R. Tuttle PrefacePart One EpidemiologyChapter 1 Epidemiology of Chronic Kidney Disease in Heart Failure Ruth C. Campbell and Ali Ahmed Chapter 2 Anemia and Cardiovascular Risk in the Kidney Disease Patients: What is the best way to achieve and what is the desired hemoglobin? Tejas V. Patel and Ajay K. Singh Part Two PathophysiologyChapter 3 Renal Hemodynamic Changes in Heart Failure Ivana Lazich and George L. Bakris Chapter 4 Changes in Kidney Function Following Heart Failure Treatment: Focus on RAS Blockade Mohammed Shakaib and George L. Bakris Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient Biff F. Palmer Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications Ivan D. Hanson and Peter A. McCullough Part Three Management of Kidney Associated Clinical ProblemsChapter 7 Hyperkalemia Risk and Treatment of Heart Failure Julian Segura and Luis M. Ruilope Chapter 8 Management of Heart Failure with Renal Artery Ischaemia Andrew K. Roy and Patrick Murray Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options Domenic A. Sica Chapter 11 Ultrafiltration and Heart Failure Paul Chacko, Donald Kikta Jr., William T. Abraham Part Four Advances in Nephropathy Management: Influences on CVD RiskChapter 12 Combination Therapy in Hypertension Treatment Raymond V. Oliva and George L. Bakris Chapter 13 Medication Adherence in Heart Failure Daniel E. Hilleman and Jennifer A. Campbell Chapter 14 New Markers of Vascular Risk David Davidson and Michael H. Davidson Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD Raghu V. Durvasula and Katherine R. Tuttle Ivana Lazich and George L. Bakris Chapter 4 Changes in Kidney Function Following Heart Failure Treatment: Focus on RAS Blockade Mohammed Shakaib and George L. Bakris Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient Biff F. Palmer Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications Ivan D. Hanson and Peter A. McCullough Part Three Management of Kidney Associated Clinical ProblemsChapter 7 Hyperkalemia Risk and Treatment of Heart Failure Julian Segura and Luis M. Ruilope Chapter 8 Management of Heart Failure with Renal Artery Ischaemia Andrew K. Roy and Patrick Murray Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options Domenic A. Sica Chapter 11 Ultrafiltration and Heart Failure Paul Chacko, Donald Kikta Jr., William T. Abraham Part Four Advances in Nephropathy Management: Influences on CVD RiskChapter 12 Combination Therapy in Hypertension Treatment Raymond V. Oliva and George L. Bakris Chapter 13 Medication Adherence in Heart Failure Daniel E. Hilleman and Jennifer A. Campbell Chapter 14 New Markers of Vascular Risk David Davidson and Michael H. Davidson Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD Raghu V. Durvasula and Katherine R. Tuttle Mohammed Shakaib and George L. Bakris Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient Biff F. Palmer Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications Ivan D. Hanson and Peter A. McCullough Part Three Management of Kidney Associated Clinical ProblemsChapter 7 Hyperkalemia Risk and Treatment of Heart Failure Julian Segura and Luis M. Ruilope Chapter 8 Management of Heart Failure with Renal Artery Ischaemia Andrew K. Roy and Patrick Murray Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options Domenic A. Sica Chapter 11 Ultrafiltration and Heart Failure Paul Chacko, Donald Kikta Jr., William T. Abraham Part Four Advances in Nephropathy Management: Influences on CVD RiskChapter 12 Combination Therapy in Hypertension Treatment Raymond V. Oliva and George L. Bakris Chapter 13 Medication Adherence in Heart Failure Daniel E. Hilleman and Jennifer A. Campbell Chapter 14 New Markers of Vascular Risk David Davidson and Michael H. Davidson Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD Raghu V. Durvasula and Katherine R. Tuttle

「Nielsen BookData」 より

詳細情報

• NII書誌ID(NCID): BB10613299
• ISBN:
  • 9781461436935
• LCCN: 2012940414
• 出版国コード: us
• タイトル言語コード: eng
• 本文言語コード: eng
• 出版地: New York
• ページ数/冊数: xiv, 248 p.
• 大きさ: 25 cm
• 分類:
  • DC23 : 616.12
• 件名:
  • LCSH : Heart failure -- Complications
  • LCSH : Cardiac arrest -- Complications
  • LCSH : Chronic renal failure